Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SERCA PHARMACEUTICALS AS
AS
Active
Org 921663846
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SERCA PHARMACEUTICALS AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
3M
4M
6M
3M
2020
2M
2021
2M
2022
4M
2023
5M
2024
EBITDA
NOK millions
0M
-1M
-3M
-4M
-5M
-4M
2020
-3M
+25%
2021
-3M
0%
2022
-4M
-33%
2023
-2M
+50%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 464
2 057
1 985
3 572
4 715
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−4 103
−2 663
−2 749
−4 421
−1 527
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−4 103
−2 663
−2 749
−4 421
−1 527
Net financials
−55
8
−46
−3
367
Profit before tax
−4 158
−2 654
−2 796
−4 424
−1 159
Tax
−0
−0
−0
−0
−0
Net profit
−4 158
−2 654
−2 796
−4 424
−1 159
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
7 395
17 275
12 569
17 924
40 622
Equity
5 314
13 467
10 671
16 391
27 645
Long-term debt
0
0
0
0
0
Short-term debt
2 081
3 808
1 897
1 532
4 362
Total debt
2 081
3 808
1 897
1 532
4 362
Financial ratios
5-year trend
EBITDA margin
-32.4%
This company
15.8%
Market median
-305% vs market
2020
2024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
2020
2024
Return on equity
-4.2%
This company
18.4%
Market median
-123% vs market
2020
2024
Net profit margin
-24.6%
This company
8.1%
Market median
-404% vs market
2020
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2020
2024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on SERCA PHARMACEUTICALS AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
